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Edited by Shou-Wei DingAbstract RNA interference (RNAi) is an RNA degradation
process that involves short, double-stranded RNAs (dsRNA) as
sequence speciﬁcity factors. The natural function of the RNAi
machinery is to generate endogenous short double-stranded
RNAs to regulate gene expression. It has been shown that treat-
ment of Plasmodium falciparum, the etiologic agent of malaria,
with dsRNA induces degradation of the corresponding mic-
roRNA (miRNA), yet typical RNAi-associated genes have not
been identiﬁable in the parasite genome. To clarify this discrep-
ancy we set out to clone short RNAs from P. falciparum-infected
red blood cells and from puriﬁed parasites. We did not ﬁnd any
short RNA that was not a rRNA or tRNA fragment. Indeed,
only known human miRNAs were isolated in parasite prepara-
tions indicating that very few if any short RNAs exist in P. fal-
ciparum. This suggests a diﬀerent mechanism than classical
RNAi in observations of dsRNA-mediated degradation. Of the
human miRNAs identiﬁed, the human miRNA mir-451 accumu-
lates at a very high level in both infected and healthy red blood
cells. Interestingly, mir-451 was not detectable in a series of
immortalised cell lines representing progenitor stages of all ma-
jor blood lineages, suggesting that mir-451 may play a role in the
diﬀerentiation of erythroid cells.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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interference1. Introduction
RNA interference (RNAi) is a sequence-speciﬁc RNA degra-
dation mechanism where long double-stranded RNA (dsRNA)
is processed by Dicer into small, double-stranded, interfering
RNAs (siRNA) that mediate degradation of RNA molecules
homologous to the siRNAs [1]. One of the siRNA strands is
incorporated into a complex called RNA induced silencing
complex (RISC) containing several proteins including argona-
ute (AGO) and this complex is guided by siRNAs to target
RNA molecules based on sequence complementarity [2]. The
target RNA is cleaved by AGO in RISC if the complementarity
is perfect between siRNA and target RNA [1]. RNAi has
proved to be a very potent research tool because long dsRNA
or siRNA can be used to knock down any gene. The natural
function of the RNAi pathway has only become clear in the last
few years with the discovery of several classes of endogenous*Corresponding author. Fax: +44 1603 592250.
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to regulate the expression of protein coding genes, transposons
and repetitive sequences [3–5]. One class of these short RNAs is
microRNA (miRNA) that is 19–24 nucleotides (nt) in length
[3]. Double-stranded (ds) miRNAs are produced from longer
precursors with hairpin structure through subsequent cleavages
by Drosha in the nucleus and Dicer in the cytoplasm [1]. After
processing, one of the strands of the ds-miRNA is incorporated
into RISC, that is subsequently guided to 3 0 untranslated
regions (UTR) of protein coding genes by the miRNA. The tar-
geting normally causes translational suppression of the target
genes in animal cells instead of cleavage because of mismatches
between miRNAs and target genes [3]. Although miRNAs have
only been found in metazoans, short RNAs of similar length
have been found in protozoa such as Tetrahymena thermophila
and Trypanosoma brucei [6,7]. In Trypanosoma brucei, RNAi is
induced by long dsRNA [8] and transposon-speciﬁc siRNAs
have been found [6]. One would expect that other organisms
with functional RNAi machinery would contain endogenous
short RNAs. In the protozoan parasite Plasmodium, dsRNA-
mediated decreases in endogenous miRNA have been observed
[9–13]. However, bioinformatic searches of the P. falciparum
genome have not been able to identify two genes (DICER
and AGO) that play a key role in the RNAi pathway [14,15].
Although there is evidence of post-transcriptional gene silenc-
ing (PTGS) and a conserved UTR in genes that are translation-
ally repressed in P. falciparum andP. berghei [16,17], it does not
necessarily validate the eﬀect of dsRNA in gene expression reg-
ulation. To elucidate this controversy, we have cloned short
RNAs from P. falciparum-infected red blood cells (RBC) to test
whether regulatory short RNAs are present in parasites. We
conducted two short RNA cloning experiments: one from
infected RBCs and another one from puriﬁed parasites – but
we were unable to ﬁnd any short RNAs that matched sequences
in the P. falciparum genome except fragments of ribosomal or
tRNA, although we found many known human miRNAs that
served as internal controls for the cloning. Unexpectedly, we
identiﬁed a highly abundant human miRNA (mir-451) [18] in
both parasitised and uninfected red blood cells. Therefore, we
assessed the expression of mir-451 in pre-erythroid cell lines
to determine its association with diﬀerentiation of erythrocytes.2. Materials and methods
2.1. RNA extraction, analysis and cloning
The short RNA fraction was puriﬁed and cloned as described in
[19]. Northern blot analysis was carried out as follows: total RNA of
malaria infected and healthy RBCs was extracted, separated on 15%blished by Elsevier B.V. All rights reserved.
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branes were hybridised with a [P32]-labelled locked nucleic acid
(LNA) oligonucleotide complementary to mir-451 as described in [19].
2.2. RNA secondary structure prediction
The secondary structures of candidate sequences were predicted by
the mfold Web server (www.bioinfo.rpi.edu/applications/mfold/old/
rna/).
2.3. Culturing malaria and human cells
Plasmodium falciparium was cultured and RNA was extracted as de-
scribed in [10]. J2E, F4N, BW5147, J558L and 416B cell lines were ob-
tained from Bertie Gottgens (University of Cambridge, UK) and were
cultured in RPMI (Gibco-Invitorgen) in the presence of 10% foetal bo-
vine serum and 2 mM L-glutamine.3. Results and discussion
3.1. Cloning short RNAs from P. falciparum-infected RBCs and
from puriﬁed parasites
Short RNAs were cloned from total RNA extracted from P.
falciparium infected RBCs following standard protocols from
mammalian microRNA cloning. Seven hundred and thirty-ﬁve
short RNAs were identiﬁed and the analysis of these sequences
is shown in Table 1. Although we expected very little human
derived short RNA since RBCs from peripheral blood are
thought to contain very low levels of RNA, more short RNAs
that matched human genome than those that matched the ma-
laria parasite genome were found. The high number of known
human miRNAs (21%) showed that the cloning was successful.
Because of the low number of potential parasite microRNAs
and the high number of human short RNAs, the cloning was
repeated using RNA extracted from puriﬁed parasites. Nine
hundred and ninety-six short sequences were obtained from
the second cloning (Table 1). There was 37-fold more parasite
rRNA fragments than human RNA demonstrating that the
RNA was indeed enriched for parasite RNA. Accordingly,
the percentage of cloned, known, human miRNAs dropped
from 21% to 4.5%. However, there was no increase in the num-
ber of potential parasite miRNAs between puriﬁed parasites
and parasitised RBC preparations. Analysis of the potential
parasite microRNAs is described below.Table 1
Distribution of cloned short RNAs
Class of RNA Plasmodium falciparum-in
Number of clones
rRNAa 382
Human rRNA 82
Plasmodium rRNA 48
Either human or malaria rRNA 84
Other rRNA 168
tRNA 22
No 100% match 136
Potential human miRNA 30
Potential Plasmodium miRNAA 10
Known human miRNA 155b
Total 735
Sequences matching any rRNA are shown in one row aligned to the left (a) an
right). Some rRNA sequences showed perfect match only to the human or to
shown as ‘‘Either human or malaria rRNA’’. Potential human and malaria m
but were not annotated. (b) The distribution of known human miRNAs is s
ASubsequently identiﬁed as pre-tRNAs.3.2. Analysis of the potential human miRNAs
The potential human miRNA sequences were analysed by
using secondary structure predictions of the sequences with
the ﬂanking genomic sequences. Two sequences out of the 30
potentials from the ﬁrst cloning and one sequence out of the
29 candidates from the second cloning showed a stable stem-
loop structure. The potential miRNA identiﬁed in the second
cloning was the same as one of the candidates from the ﬁrst
cloning and was found three times in the ﬁrst cloning and 15
times in the second. Northern blot analysis conﬁrmed the accu-
mulation of this potential miRNA (Fig. 1) but the other can-
didate was not detectable and was not analysed further. The
conﬁrmed miRNA has recently been published by Altuvia
et al. [18] and named mir-451. It was discovered by bioinfor-
matic prediction of novel miRNAs by searching for miRNA
precursor like sequences in the vicinity of known miRNA
genes. Mir-451 was found next to mir-144 and found to be ex-
pressed in pituitary gland RNA [18].
3.3. Analysis of potential malaria miRNAs
The potential Plasmodium miRNA sequences were identi-
ﬁed based on perfect matches to the P. falciparum genome
that were not annotated as rRNA or tRNA. Initially the gen-
ome sequence at http://www.sanger.ac.uk/Projects/P_falcipa-
rum/ was analysed by the recommended Artemis genome
browser program. However, when these candidate sequences
were further analysed using the annotated gene database at
www.plasmodb.org, they proved to all be associated with pre-
cursor tRNA sequences. The encoded sequences were the sta-
ble, double-stranded, stem structure of pre-tRNAs that is
cleaved during tRNA maturation. This ﬁnding was conﬁrmed
by Northern blots with the short RNA sequences where the
only signals were higher than 100 nt (data not shown). There-
fore, we did not ﬁnd any Plasmodium miRNAs, siRNAs or
other regulatory short RNAs. In the case of negative data,
the reliability of data is important and it is vital whether we
are working above the detection level. In this case, for exam-
ple, it may be that the RNA used for the short RNA cloning
was degraded and therefore the fragmented rRNA and tRNA
molecules that were in the 19–24 nt region masked the real
miRNAs or siRNAs. However, the cloned human miRNAsfected RBC Puriﬁed Plasmodium falciparum
% Number of clones %
52 743 74.8
11.3 9 1
6.5 370 37.2
11.4 261 26.3
22.8 103 10.3
3 7 0.8
18.5 155 15.7
4 29 3.0
1.5 11 1.2
21 44b 4.5
100 996 100
d they are further grouped based on the origin of rRNA (aligned to the
the malaria genome but some of them were identical to both. These are
iRNAs were short RNAs that showed perfect match to either genome
hown in Supplementary Table 1.
Fig. 1. Accumulation of mir-451 in malaria infected and healthy RBCs RNA was extracted from puriﬁed malaria infected or healthy RBCs,
separated on denaturing gel and blotted to a membrane. The membrane was hybridised with an end-labelled mir-451 speciﬁc LNA probe.
Unexpectedly, mir-451 could be detected in 1 ng total RNA of healthy RBCs and showed a reduced accumulation in infected cells. RNA
oligonucleotides 19 and 24 in length were used as size markers (shown on the left).
Fig. 2. Mir-451 is not expressed in precursor cell lines of blood cell
lineages. Top panel: Northern blot analysis of 50 lg total RNA
extracted from cell lines J2E (lane 3), F4N (lane 4), BW5147 (lane 5),
J558L (lane 6) and 416B (lane 7) showed that mir-451 was not
expressed in these cell lines. The positive control RNA (2 lg) extracted
from Plasmodium-infected RBCs showed a strong mir-451 signal (lane
2). Size markers (19 and 24 nt RNA oligonucleotides) are shown in
lane 1. Bottom panel: Ethidium bromide stained picture of the
polyacrylamide gel before blotting shows that only 2 lg total RNA
was loaded from the Plasmodium-infected RBCs whereas 50 lg total
RNA was loaded from cell lines.
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from the number of human and Plasmodium-speciﬁc rRNA
fragments that there was at least 40 times more Plasmodium
RNA than human RNA in the sample, if we assume that
human and parasite rRNA molecules had similar ability to
produce 19–24 nt fragments by chance. In spite of this huge
over-representation, we only cloned human miRNAs and
not a single regulatory short RNA from Plasmodium. Includ-
ing the newly identiﬁed mir-451, the number of cloned human
miRNAs is even higher than shown in Table 1 with 59 (44
known miRNA plus the 15 times represented mir-451 in the
group of potential miRNAs) of the 82 cloned human short
RNAs (the sum of known and potential miRNAs and human
rRNA; 44, 29 and 9, respectively) identiﬁable as miRNAs (i.e.
72%). In contrary, none of the cloned 381 malaria short RNA
proved to be miRNA or siRNA. This data shows that if there
is any regulatory short RNA in erythrocyte stages of P. falci-
parum, we would expect them to have been cloned, since the
majority of the small amount of contaminating human short
RNAs were miRNAs. If miRNAs exist in P. falciparum then
they are not 19–24 nt or do not contain the canonical 3 0 hy-
droxyl and 5 0 phosphate that were the basis of our cloning
[19].
The lack of identiﬁable miRNAs in Plasmodium corresponds
with the lack of obvious Dicer and AGO genes in the RNAi
machinery [14,15]. Based on these data, there is no support
for functional RNAi machinery in P. falciparum yet several
laboratories have independently observed dsRNA-dependant
degradation of homologous mRNA. The dsRNA-dependent
degradation must therefore utilise a diﬀerent mechanism [8–
11,13]. We cannot rule out the possibility that RNAi factors
(like siRNA containing RISCs) are transported into the intra-
cellular parasites from the human cell and these would be
responsible for the observed RNAi eﬀects. Further investiga-
tions are required to delineate the mechanism of dsRNA-med-
iated inhibition.
3.4. Accumulation of mir-451 in peripheral RBCs and in cell
lines
We next asked the question whether mir-451 is a parasite-
speciﬁc response or found in uninfected erythrocytes. Mir-
451 was found to accumulate at high levels in healthy RBCs
puriﬁed from peripheral blood (Fig. 1); hence accumulation
of mir-451 is independent of parasite infection. The signal
was exceptionally strong indicating high levels of this miRNA
therefore we further investigated the level of mir-451 in periph-
eral RBCs. A dilution series (Fig. 1) revealed that mir-451
expression can be detected by loading as little as 1 ng totalRNA and exposed only overnight. This level is exceptional
for a miRNA relative to total RNA levels. Mir-451 is therefore
one of the principal RNAs found in erythrocytes.
The mouse mir-451 gene is located 100 bp away from mir-
144 [18] in the genome and therefore both miRNAs are ex-
pected to derive from the same transcript and have similar
expression patterns. Wienholds et al. [20] analysed the expres-
sion pattern of zebraﬁsh miRNAs by whole mount in situ
hybridisation and found that mir-144 was expressed speciﬁ-
cally in blood, which supported by our ﬁnding that mir-451
is expressed in RBCs of peripheral blood.
Next we asked whether mir-451 was speciﬁc for mature
erythrocytes by assessing expression in cell lines representing
the progenitor stages of all major blood lineages. We surveyed
5188 T. Rathjen et al. / FEBS Letters 580 (2006) 5185–5188expression in J2E, F4N, BW5147, J558L and 416B cell lines
representing progenitors of fetal liver erythroid, bone marrow
erythroid, T-cell, B-cell and multipotent precursor stages,
respectively. In sharp contrast to mature erythrocytes, none
of these cell lines expressed mir-451 at detectable levels
(Fig. 2). Unlike erythrocytes, these cell lines are actively tran-
scribing their nuclear complement of genes and are undiﬀeren-
tiated. Our ﬁndings are therefore consistent with the notion
that mir-451 expression plays a role in the diﬀerentiation
and/or maturation of primary RBCs. Identiﬁcation of target
genes regulated by mir-451 will shed light on the biological role
of this miRNA. There are 842 predicted target genes of mir-
451 (http://microrna.sanger.ac.uk/) and it requires further
studies to identify and validate the real targets from this list
of candidates.
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